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Abstract
The progression of obesity is accompanied by a chronic inflammatory process that involves both innate and acquired
immunity. Natural killer T (NKT) cells recognize lipid antigens and are also distributed in adipose tissue. To examine the
involvement of NKT cells in the development of obesity, C57BL/6 mice (wild type; WT), and two NKT-cell-deficient strains,
Ja18
2/2 mice that lack the type I subset and CD1d
2/2 mice that lack both the type I and II subsets, were fed a high fat diet
(HFD). CD1d
2/2 mice gained the least body weight with the least weight in perigonadal and brown adipose tissue as well as
in the liver, compared to WT or Ja18
2/2 mice fed an HFD. Histologically, CD1d
2/2 mice had significantly smaller adipocytes
and developed significantly milder hepatosteatosis than WT or Ja18
2/2 mice. The number of NK1.1
+TCRb
+ cells in adipose
tissue increased when WT mice were fed an HFD and were mostly invariant Va14Ja18-negative. CD11b
+ macrophages (Mw)
were another major subset of cells in adipose tissue infiltrates, and they were divided into F4/80
high and F4/80
low cells. The
F4/80
low-Mw subset in adipose tissue was increased in CD1d
2/2 mice, and this population likely played an anti-inflammatory
role. Glucose intolerance and insulin resistance in CD1d
2/2 mice were not aggravated as in WT or Ja18
2/2 mice fed an HFD,
likely due to a lower grade of inflammation and adiposity. Collectively, our findings provide evidence that type II NKT cells
initiate inflammation in the liver and adipose tissue and exacerbate the course of obesity that leads to insulin resistance.
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Introduction
Obesity is thought to progress with caloric excess under a
chronic inflammatory process characterized by infiltration of
adipose tissue by Mw and by cells of the adaptive immune system,
such as T cells [1–3]. The inflammation in adipose tissue induces
alterations in metabolic and endocrine functions of adipocytes,
which leads to insulin resistance and various pathological
responses [4,5]. Recent studies by Nishimura et al revealed the
active participation of CD8
+ T cells in chronic inflammation in
adipose tissue [6]. Moreover, CD4
+Foxp3
+ T cells with unique
specificity have been detected in adipose tissue and were suggested
to regulate the development of obesity by suppressing inflamma-
tory responses [7]. Furthermore, additional findings showed that
the transfer of CD4
+ T cells from WT but not from T-cell receptor
transgenic mice ameliorated the metabolic dysregulation in Rag-
1
2/2 mice fed a high fat diet (HFD), which led to the idea that
CD4
+ T cells play a suppressive role in diet-induced obesity (DIO)
[8]. These studies have indicated that T cells that infiltrate adipose
tissue are not just inert bystanders but are active modifiers of
inflammation and thus either aggravate or ameliorate obesity.
Natural killer T (NKT) cells are a unique subset of T-lineage
cells that recognize various lipid antigens in the context of CD1d
molecules [9]. Among lipid ligands, a-galactosylceramide (a-
GalCer) is the prototype ligand [10] that can stimulate NKT cells
to promptly produce large amounts of various cytokines and
chemokines and also demonstrate cytocidal activity [11]. Endog-
enous ligands can also stimulate NKT cells to perform their innate
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where lipid metabolism is active, and in adipose tissue [14], another
location for lipid metabolism with endocrine functions. These
considerations led us to suggest that, NKT cells might play a role
in a disease that involves abnormal lipid metabolism or lipid-related
inflammation. Indeed, several research groups including our team
have demonstrated that NKT cells accelerate atherogenesis in a
mouse model of atherosclerosis [15–17]. Furthermore, we have
examined the involvement of NKT cells in insulin resistance induced
in mice fed an HFD and demonstrated that NKT cells play an
importantroleinadipose-tissueinflammationandglucoseintolerance
in b2-microglobulin knockout (b2m
2/2)m i c ew i t hD I O[ 1 8 ] .
However, both mainstream CD8
+ Tc e l l sa n dv a r i o u si n n a t e
lymphocytes other than NKT cells also are absent in b2m
2/2 mice
[19]. Thus, we attempted to examine the involvement of NKT cells
in DIO and insulin resistance using NKT cell-deficient mice. To this
end, we compared B6 (WT) and two strains of NKT cell-deficient
mice, CD1d
2/2 and Ja18
2/2 mice on a B6 genetic background.
Unlike our previous study in b2m
2/2 mice [18], DIO was
significantly suppressed in CD1d
2/2 mice compared to WT mice.
Moreover, in Ja18
2/2 mice where type I but not type II NKT cells
were deficient, DIO was induced to an equal extent as in WT mice.
The possible mechanisms underlying lipid-induced NKT-cell
activation and the development of chronic inflammation by type II
NKT cells in DIO are discussed.
Materials and Methods
Mice
Male and female 8-week-old C57BL/6 (B6; Nippon SLC,
Shizuoka, Japan), B6.CD1d
2/2 [20], and B6.Ja18
2/2 [21] mice
were used. Mice were maintained on food and water ad libitum
until they reached the desired weight (20–24 g) or age (8 wk)
under specific pathogen-free conditions. All experiments were
approved by the Committees of Animal Experimentation at
Hokkaido University (permit number: #09-0022) and Kitasato
University (permit number: #2011 105).
Diet-induced obesity
Mice were fed either regular chow as a standard fat diet (SFD;
Nihon Nosan: fat 4.3%, cholesterol 0.03%, protein 18.3%,
carbohydrate 58.3%) or an HFD (CLEA Japan HFD-32: fat
(powdered tallow and safflower oil of high oleic type) 32.0%, protein
25.5%, fiber 2.9%, mineral 4.0%, nitrogen 29.4%, water 6.2%)
starting from 8 wk ofage for 18 wk.Micewereweighed weekly.The
ingredients of HFD-32 are listed in detail at ,http://www.clea-
japan.com/Feed/pdf/clea_hfd32.pdf.. Major fatty acids included
oleic acid (C18:1; 64.3%), palmitic acid (C16:0; 12.6%), linoleic acid
(C18:2; 10.2%), and stearic acid (C18:0; 7.5%). After 18 wk of feeding,
mice were sacrificed for analysis. For some experiments, mice were
injected intraperitoneally with a-GalCer (0.1 mg/g body weight,
BW) or vehicle as control to examine the change of BW.
Blood chemistry
Total cholesterol (T-chol), high-density lipoprotein (HDL) choles-
terol (HDL-chol), triglyceride (TG), and alanine aminotransferase
(ALT) concentrations in sera were quantified by colorimetric assays
with the Fuji Drychem system (Fujifilm Medical, Osaka, Japan)
according to the manufacturer’s protocol, as described elsewhere [16].
Histology and quantitative analyses of microscopic
images
Perigonadal fat tissue was removed and fixed with buffered
formaldehyde solution (10%) followed by ordinary processing for
paraffin-embedded sections and hematoxylin-eosin (HE) staining.
Images of the HE-stained adipose tissue were incorporated with a
BIOREVO microscope (BZ8100; Keyence Corp., Osaka, Japan),
and morphometric analyses were performed with image analysis
software (BZ-H2A, -H1C) equipped on the microscope. Liver
samples were snap-frozen in OCT compound (Sakura Finetek
Co., Tokyo, Japan) with liquid nitrogen, and cryosections were
stained with Oil Red O (ORO) (Sigma Chemical Co., St. Louis,
MO) and Meyer’s hematoxylin (Wako Pure Chemical Co. Ltd.,
Osaka, Japan). Images of lipid droplets in hepatocytes stained red
were quantified by computerized image analysis system (Scion
Image software, Scion Corp., Frederick, MD).
Flow cytometry
Splenocytes were prepared by mincing the spleen with a glass
homogenizer, and red blood cells were lysed with Tris-NH4Cl
solution. Hepatic mononuclear cells (HMNC) were isolated from
liver homogenates by density-gradient centrifugation with 33%
Percoll
TM (GE Healthcare Life Sciences, Piscataway, NJ) as
previously reported [22]. Stromal vascular cells were isolated from
the digest of perigonadal fat by mincing and incubating with
collagenase D solution (2 mg/ml) (Roche Diagnostics, Indianap-
olis, IN) for 1–1.5 h. The cells were incubated with 2.4G2
monoclonal antibody (mAb) (anti-FccRIII/II) to block non-
specific binding of primary mAb and then reacted with CD1d:Ig
recombinant fusion protein (BD Biosciences Pharmingen, San
Diego, CA) loaded with a-GalCer (a-GalCer-CD1d-dimer),
followed by detection with phycoerythrin (PE)-conjugated anti-
mouse IgG1 mAb (A85-1; BD) according to the manufacturer’s
protocol [16]. After washing, cells were stained with a combination
of the following mAb conjugates: fluorescein isothiocyanate
(FITC)-anti-TCRb chain (H57-597; BD), -anti-CD3e (145-2C11;
BD), -anti-CD1d (1B1; BD), -anti-CD206 (MR5D3; BioLegend,
San Diego, CA), -rat IgG2a (BD), -rat IgG2b (BD), allophycocyanin
(APC)-anti-NK1.1 (PK136; BD, BioLegend), -anti-CD11c (HL3;
BD), -Streptavidin (BioLegend), PE-anti-CD4 (RM4-5; BD), -anti-
CD8 (53-6.7; BD), -anti-CD11b (M1/70; BioLegend), and APC-
Cy7-Streptavidin (BD). Stained cells were acquired with FACS
Calibur or Canto II flow cytometers (BD Bioscience Immunocy-
tometry Systems, San Jose, CA) and analyzed with CellQuest,
FACS Diva (BDIS), or FlowJo (Tommy Digital Biology, Tokyo,
Japan) software as described elsewhere [16]. Propidium iodide (PI;
Sigma) or 7-aminoactinomycin D (7-AAD; BD) positive cells were
electronically gated as dead cells from the analysis.
Quantification of serum cytokines and adipokines
The concentration of Th1/Th2 and inflammatory cytokines,
including IFN-c, tumor necrosis factor (TNF)-a, IL-1a,2 ,4 ,5 ,6 ,
10, 17, and GM-CSF in serum was quantified with Mouse Th1/
Th2 10plex FlowCytomix
TM Multiplex (Bender MedSystems
GmbH, Vienna, Austria) according to the manufacturer’s protocol
with a flow cytometer. Leptin (Morinaga Institute of Biological
Sciences, Kanagawa, Japan) in sera was respectively quantified
with enzyme-linked immunosorbent assay (ELISA) kit according
to the manufacturers’ protocol.
IPGTT and insulin tolerance test
Intraperitoneal (i.p.) glucose tolerance test (IPGTT) was
performed by i.p. injection of glucose solution (1 g/kg) after 16 h
of fasting [6]. The insulin tolerance test (ITT) was performed by
i.p. injection of insulin (0.751U/kg; Humulin R 100 U/ml; Eli
Lilly Japan KK, Kobe, Japan) after 3.5 h of fasting. The blood
glucose level was serially quantified with a blood glucose monitor
(MEDISAFE MINI; Terumo Corp., Tokyo, Japan). The insulin
Role of Type II NKT Cells on Diet-Induced Obesity
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(Morinaga) according to the manufacturer’s protocol.
HMNC transfer
HMNC were obtained from either Ja18
2/2 or CD1d
2/2 mice
and were intravenously transferred to CD1d
2/2 recipient mice
(1610
6/mouse) at 8 wk. These mice were fed an HFD for 14
weeks and tested for IPGTT and ITT as above.
Culture of MQ from the stromal vascular fraction (SVF) of
adipose tissue
Cells (1610
5/well) obtained from perigonadal adipose tissue
were cultured in RPMI medium (supplemented with 10% heat-
inactivated fetal calf serum, 100 U/ml penicillin, 100 mg/ml
streptomycin, and 50 mM b-mercaptoethanol) with 1 mg/ml LPS
for 20 h. After 20 h, supernatants were collected and frozen at
280uC, and cytokines were later quantified as described above.
Statistical analysis
Results were demonstrated as means 6 standard deviation (s.d.).
Statistical analysis between two groups was performed by
Student’s t-test and among three groups was performed using
ANOVA followed by Tukey-Kramer tests. Pearson’s correlation
coefficient test was used to examine the correlation. Values with
P,0.05 were considered statistically significant.
Results
Impact of the presence of NKT cells on the weight gain of
mice fed an HFD
Female or male B6 (WT), B6.Ja18
2/2 (Ja18
2/2), and
B6.CD1d
2/2 (CD1d
2/2) mice were fed either an SFD or an
HFD from 8 wk to 22,26 wk of age (for 14,18 wk), and the BW
of each group of mice was plotted over time. Three groups of
female (Figure 1A) or male (Figure 1B) mice showed a similar and
gradual increase of BW when fed an SFD. On the other hand, all
groups of female and male mice gained substantially more BW on
HFD than those on SFD. However, CD1d
2/2 mice showed
significantly less gains than those of WT and Ja18
2/2 mice
(Figure 1A, B). Consistently, the least difference was observed in
CD1d
2/2 mice when the net gain ([BW on HFD at n wk]2[BW
on HFD at 8 wk]: n$8 wk) was compared (Figure 1C, D). We also
compared BW in WT mice that received either the prototypical
type I NKT cell ligand a-GalCer or vehicle when fed either an
SFD or an HFD. There was no significant difference in weight
gain between mice that received a-GalCer or vehicle and fed
either an SFD or an HFD (Figure S1A), suggesting that type I
NKT cells might have a minimal role in the development of DIO
even when the activating ligand is provided.
When the daily food intake per animal was compared in each
group of mice by calculating S[(amounts given2amounts left)/
total periods] throughout the feeding periods, CD1d
2/2 female
Figure 1. Body weight and weight gain of three strains of mice fed an SFD or an HFD. (A, B) Body weight (BW) of female (A) and male mice
(B) fed a high-fat diet (HFD) or a standard-fat diet (SFD) at 8 wk and weighed weekly. (n=3–7 in each group) (C, D) Representative data of three
similar experiments are shown. Weight gain (DBW=BWnw k 2BW8w k ;n $9) of female (C) and male (D) mice. Each point represents mean 6 standard
deviation (s.d.). Statistical analysis was performed according to the Tukey-Kramer test. **p,0.01 (WT and Ja18
2/2 vs CD1d
2/2).
doi:10.1371/journal.pone.0030568.g001
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the other two strains, WT and Ja18
2/2 mice (Figure 2A). A
similar tendency in food intake was observed in male mice (data
not shown).
The BW of CD1d
2/2 mice was significantly lower than that of
WT and Ja18
2/2 mice after 18 wk of HFD feeding (Figure 2B)
(WT=Ja18
2/2.CD1d
2/2; p,0.01 between WT and CD1d
2/2;
Ja18
2/2 and CD1d
2/2). The difference in BW in each group of
mice was attributable to the sum of the differences in weights of
organs and tissues. Thus, the liver, perigonadal fat tissue (white
adipose tissue; WAT) and fat tissue between the scapulae (brown
adipose tissue; BAT) of each group were obtained and compared.
Consistent with the differences in BW, CD1d
2/2 mice had lower
liver weight (Figure 2C) (WT=Ja18
2/2.CD1d
2/2; p,0.01
between WT and CD1d
2/2; p,0.05 between Ja18
2/2 and
CD1d
2/2), lower WAT weight (Figure 2D) (WT$Ja18
2/2
.CD1d
2/2; p,0.01 between WT and CD1d
2/2;J a18
2/2 and
CD1d
2/2) and lower BAT weight (Figure 2E) (WT$Ja18
2/2
.CD1d
2/2; p,0.01 between WT and CD1d
2/2), when com-
pared to those of sex-matched WT or Ja18
2/2 mice fed an HFD
(closed bar). In SFD-fed mice, there were no significant differences
in the weights of the whole BW, liver, WAT, and BAT among the
three groups of mice (Figure 2B–E; open bar).
When serum lipids were quantified in the three groups of mice
fed an HFD, WT and Ja18
2/2 mice exhibited significantly higher
levels of T-chol- and HDL-chol than CD1d
2/2 mice (Figure S2A,
B). The cholesterol level was consistent with the extent of
adiposity, whereas the TG level was not different among the
three groups (Figure S2C).
HFD-induced hepatosteatosis and adipocyte
hypertrophy are ameliorated in CD1d
2/2 mice
First, livers were histologically examined for major causes of
weight gain among three strains of mice on HFD. WT and Ja18
2/2
mice on HFD had marked hepatosteatosis, which was revealed by
reddepositson ORO staining (Figure 3A). Onthe otherhand,livers
of CD1d
2/2 mice that appeared less fatty exhibited lighter deposits
on ORO staining (Figure 3A). The ORO-positive regions in
CD1d
2/2 livers were significantly smaller than those of WT and
Ja18
2/2 mice (Figure 3B). The severity of steatosis appeared
consistent with the liver weight and dyslipidemic level in each strain
(Figure 2A and B). Furthermore, the ALT level, a marker of liver
damage,wassignificantlysuppressedinCD1d
2/2mice(Figure3C).
We also quantified pro-inflammatory cytokines that were secreted
from HMNC in mice fed an HFD upon stimulation with LPS.
Production of IL-6 and TNF-a in culture supernatants was
increased in WT and Ja18
2/2 mice, whereas it was suppressed in
HMNC cultures of CD1d
2/2 mice (Figure 3D, E). Thus, lipid-
induced inflammation may be suppressed in the absence of CD1d
and CD1d-restricted NKT cells.
Next, we similarly analyzed adipose tissues that also contribute
to the difference in BW in the three groups of mice. CD1d
2/2
mice had apparently smaller adipocytes in adipose tissue even on
HFD, whereas enlarged adipocytes occupied the entire tissue in
WT and Ja18
2/2 mice (Figure 4A). Of note, boundaries of
adipocytes formed almost straight lines due to the close packing of
adipocytes in WT mice (Figure 4A left panel). To compare
adipocyte size in WAT of each group of mice, the circumference of
Figure 2. Physiological parameters of three strains of female mice fed an SFD or an HFD. (A) Food intake of mice in each group (g/mouse/
day). (B–E) The body, liver, perigonadal adipose tissue (WAT), and brown adipose tissue (BAT) were weighed after 18 wk of feeding at 26 wk of age
(n=3–7 in each group). Representative data of three similar experiments are shown. The results are expressed as mean 6 s.d. Statistical analysis was
performed according to the Tukey-Kramer test. *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0030568.g002
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adipocytes from CD1d
2/2 mice had significantly smaller
circumference than those from WT and Ja18
2/2 mice.
When leptin is overexpressed, mice demonstrate a lean
phenotype [23]. To examine whether CD1d
2/2 expressed a
higher level of leptin in sera than WT and Ja18
2/2 mice, serum
leptin levels were quantified. However, CD1d
2/2 showed the
lowest level among the three strains of mice, which was
proportional to the volume of WAT (Figure 4C).
Analysis of infiltrated cellular components in liver of mice
fed an HFD
Our findings thus far showed that adiposity and hepatosteatosis
were similar between WT and Ja18
2/2 but were minimal in
CD1d
2/2 mice. The difference between Ja18
2/2 and CD1d
2/2
mice is solely the absence of type II NKT cells selected by CD1d in
CD1d
2/2 but not Ja18
2/2 mice. To study the relationship
between type I (iNKT) and type II NKT cells, we analyzed NKT
cellsubsetsin liverand adipose tissue ofeach strain. Asshown inour
previous report with the short term feeding of HFD [18], the
proportion of NKT cells in liver decreased in WT mice fed an HFD
comparedtomice onanSFDwhenthe HMNCfractionwasstained
with a combination of either a-GalCer-loaded CD1d-dimer and
anti-TCRb mAb (iNKT cells) (Figure 5A-a, b; 22.8%2.6.8%) or
anti-NK1.1 and TCRb mAb (total NKT cells, including NKT-like
cells) (Figure 5A-c, d; 27.9%2.6.6%). To detect the subset of type
II NKT cells and NKT-like cells in the iNKT cell-deficient strains,
the latter combination was employed. Although a significant
decrease was demonstrated in NKT cells in WT mice (Figure 5B-
a),therewasnosignificantdifference intheproportionoftotalNKT
cells in Ja18
2/2 and CD1d
2/2 mice fed an HFD (Figure 5B-a), but
Ja18
2/2 mice appeared to exhibit a slight decrease in the
prevalence of these cells on an HFD. To examine the residual
NKT-like cells in the livers of Ja18
2/2 and CD1d
2/2 mice,
staining with a combination of anti-NK1.1 and anti-TCRb mAb
was employed. As demonstrated in the FACS profiles, total NKT
cells in WT mice were significantly decreased after HFD feeding
(Figure 5B-a). As for the subset of residual NKTcells, the subset that
expressed neither CD4 nor CD8 (CD4
28
2 double negative; DN)
did not differ regardless of the feeding regimen used or the mouse
strains analyzed. The relative prevalence of the CD4
+8
2 subset was
as follows: WT.Ja18
2/2.CD1d
2/2 mice, and the prevalence of
the CD4
28
+ subset had an inverse relationship with CD8
+ cells
(WT,Ja18
2/2,CD1d
2/2 mice) (Figure 5B-b, c). Although the
total number of liver NKT cells was reduced, the residual
population was mainly a CD4
+ subset in WT mice and the
remaining cells were a CD4
28
2 subset (Figure 5B-d). The CD8
+
subset was very minimal in WT mice. On the other hand, CD1d
2/
2 mice had residual numbers of hepatic NK1.1
+TCRb
+, NKT-like
cells, and about 40,50% of the population was CD8
+. There was
no significant differencein the proportionof regulatory T (Treg) cells
in HMNC among the three strains of mice (data not shown). It
should be noted that NKT cells in the liver of WT mice fed with
HFD were significantly reduced. This effect of lipid excess was
evident as early as day 1 of HFD feeding (data not shown).
Analysis of infiltrated cellular components in adipose
tissue of mice fed an HFD
The SVF in adipose tissue contains innate lymphocytes and Mw
even under normal conditions. In adipose tissue in obese mice, we
Figure 3. Histology and cytokine production in the liver. (A) A liver section was stained with ORO (frozen section) in SFD- and HFD-fed mice.
(B) Red-stained lipid droplets in liver sections of HFD-fed mice were quantified with image analysis software. (C) Serum levels of ALT were quantified
with the Drychem system. (D, E) The production of cytokines from HMNC of HFD-fed mice stimulated with LPS for 20 h (n=3–4 female mice in each
group). The results are expressed as mean 6 s.d. Statistical analysis was performed according to the Tukey-Kramer test. *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0030568.g003
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lean mice in spaces surrounded by adipocytes (data not shown).
First, we analyzed NK1.1
+TCRb
+ (NKT) cells and the CD4/8
subsets. Since the CD1d-restricted NKT cells are absent in
CD1d
2/2 mice, we used NK1.1
+TCRb
+ staining to detect
residual NKT-like cells instead of double stainig with a
combination of a-GalCer-loaded CD1d-dimers and anti-TCRb
mAb. In WT mice, the proportion of iNKT cells in adipose tissue
was not significantly different (Figure 6A-a, b; 1.5%2.1.2%),
whereas there were significantly more NK1.1
+TCRb
+ cells in mice
fed an HFD compared to those on SFD, in the same experimental
setting (Figure 6A-c, d; 2.2%2.5.2%). The percentage of NKT
cells increased in WT and Ja18
2/2 cells when the NKT cells of
mice on HFD were compared with those on SFD (WT; p,0.05;
Ja18
2/2; p,0.01), whereas such an increase was not observed in
CD1d
2/2 mice (Figure 6B-a). Since CD1d
2/2 mice lack CD4
+
CD1d-restricted NKT cells, there were significant differences in
the percentages (Figure 6B-b) (WT; p,0.05; Ja18
2/2; p,0.01)
and actual cell numbers (WT, Ja18
2/2; p,0.05). Of note, the
CD8
+ subset was prominently increased in the adipose tissue of
Ja18
2/2 mice both in percentage (Figure 6B-c) and in number.
The CD4
28
2 subset of NKT cells appeared to be significantly
decreased in Ja18
2/2 mice fed an HFD, most likely due to the
relative abundance of the CD4
28
+ subset (Figure 6B-d). Similar
results were obtained when analyzing actual cell numbers
(WT.Ja18
2/2.CD1d
2/2) (data not shown).
We analyzed and compared the proportion of NKT cells at
early and late phases (18-wk) of HFD feeding. In WT mice, the
number of a-GalCer-CD1d-dimer
+ cells and NK1.1
+TCRb
+ cells
in liver were increased at 1 wk of HFD-feeding, and numbers
tended to decrease thereafter (Figure S3A). On the other hand,
these cells, especially the NK1.1
+TCRb
+ population, were
gradually increased in adipose tissue (Figure S3B). The increase
in NK1.1
+TCRb
+ cells (percentage in SVF) in adipose tissue
correlated with BW in WT and Ja18
2/2 mice, whereas no
correlation was found in CD1d
2/2 mice (Figure 6C). A similar
correlation was obtained between numbers of NK1.1
+TCRb
+ cells
(cell number/g adipose tissue) and BW (data not shown).
Analysis of MQ in adipose tissue and cytokine production
upon LPS stimulation
MQ are another major cellular subset in SVF and may affect the
metabolism of adipose tissue. Therefore, SVF preparations from
the three strains of mouse were stained with F4/80 and CD11b
(Figure 7A). The three strains had a similar pattern of F4/80
+/
CD11b
+ staining. Although we anticipated that CD1d
2/2 mice
had fewer MQ than Ja18
2/2 mice, the percentage of F4/80
+/
CD11b
+ cells in CD1d
2/2 mice was higher than that of Ja18
2/2
mice (Figure 7B-a). However, when the F4/80
+ population was
divided into two subpopulations according to the MFI of F4/80
staining pattern, i. e., Population 1 (P1: F4/80
high) and Population
2 (P2: F4/80
low,2) cells (both CD11b
+), WT mice had higher
frequencies of P1 than Ja18
2/2 mice (Figure 7B-b), whereas
CD1d
2/2 mice had an increased frequency of P2 than WT and
Ja18
2/2 mice (Figure 7B-c). Analyses of actual cell numbers
Figure 4. Histology of perigonadal adipose tissue and serum leptin level. (A, B) A paraffin section of perigonadal adipose tissue was stained
with HE, and the circumference of adipocytes was morphometrically analyzed (10610, 300–400 adipocytes measured) in HFD mice. (C) The serum
leptin level was quantified by ELISA (n=3–4 female mice in each group). Representative data of two similar experiments are shown. The results are
expressed as mean 6 s.d. Statistical analysis was performed according to the Tukey-Kramer test. *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0030568.g004
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(data not shown). Of note, a higher MFI of CD1d expression was
detected in the cells of the P1 population compared with the P2
population, both in WT and Ja18
2/2 mice (Figure 7C-a, b, c).
To examine functional differences in a specific Mw population,
total cells from the SVF fraction were stimulated with LPS for
20 h and cytokines were measured (Figure 8). IL-10 levels were
significantly higher in SVF cultures from CD1d
2/2 mice
compared with WT mice (Figure 8A), and GM-CSF was
significantly lower in Ja18
2/2 and CD1d
2/2 mice (Figure 8B).
Notably, the production of TNF-a in the culture supernatant that
could affect insulin resistance was not significantly different among
the three strains (Figure 8C).
Glucose and insulin tolerance are ameliorated CD1d
2/2
mice
Since the pattern of adiposity should reflect levels of glucose
intolerance, IPGTT was performed in the three mouse strains
(Figure 9). No difference was observed in fasting blood sugar levels
and in elevation after i.p. administration of glucose over time in the
three strains fed an SFD (Figure 9A, left). On the other hand,
CD1d
2/2 mice demonstrated the lowest fasting blood sugar level
and a suppressed elevation profile after glucose administration
among the three strains on an HFD (Figure 9A, right). Insulin
levels were significantly higher in WT and Ja18
2/2 mice before
and at 120 min after infusion than that obtained in the respective
groups on an SFD (data not shown) and for CD1d
2/2 mice on an
HFD, suggesting that insulin resistance was present in those strains
(Figure 9B). To further examine insulin resistance, an ITT was
performed in HFD-fed mice that had been fasted for 3.5 h [6]
(Figure 9C). Following injection of insulin, blood glucose levels fell
most prominently in CD1d
2/2 mice at 30 and 60 min after the
injection (Figure 9C). The decrease in glucose level in WT mice
injected with a-GalCer was less than that of mice injected with
vehicle (Figure S1B), suggesting that insulin resistance was
reproduced in mice when iNKT cells were activated [18],
although there was no net increase in BW with the treatment.
Thus, CD1d
2/2 mice developed the least resistance to insulin in
the absence of both iNKT and type II NKT cells.
To examine whether type II NKT cells alone could reproduce
the pathophysiological status observed in Ja18
2/2 mice, HMNC
obtained from either Ja18
2/2 or CD1d
2/2 mice were intrave-
nously transferred to CD1d
2/2 recipient mice and weight gain
was examined on an HFD. CD1d
2/2 mice that received HMNC
from Ja18
2/2 mice showed a slight increase in BW and exhibited
a less profound decrease in blood glucose levels in the ITT (Figure
S4A, C). Although no significant difference was detected with the
IPGTT (Figure S4B), CD1d
2/2 mice that received HMNC from
Figure 5. Flow cytometric analyses of HMNC in mice fed an SFD or an HFD. (A) A representative flow cytometric dot-plot defining the
population of a-GalCer/CD1d dimer
+TCRb
+ and NK1.1
+TCRb
+ cells in the liver of SFD-fed mice (a, c) and HFD-fed mice (b, d). (B) The proportion of
NK1.1
+TCRb
+ cells (a), CD4
+ (b), CD8
+ (c), and CD4
2CD8
2 (d) NKT cells (n=3–6 female mice in each group). Representative data of three similar
experiments are shown. The results are expressed as mean 6 s.d. Statistical analysis was performed according to the Tukey-Kramer test. *p,0.05,
**p,0.01.
doi:10.1371/journal.pone.0030568.g005
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2/2 mice showed higher insulin resistance than CD1d
2/2
mice that received HMNC from CD1d
2/2 mice. The percentage
of NKT cells (NK1.1
+ TCRb
+) and CD4
+ NKT cells was similar
in the liver and adipose tissue of CD1d
2/2 hosts (Figure S4D-a, b).
However, CD8
+ NK1.1
+ T cells in adipose tissue were significantly
increased in mice transferred with HMNC from Ja18
2/2-mice
(Figure S4D-c), similarly to what we observed in Ja18
2/2 mice fed
an HFD.
Discussion
Adipocytes, MQ and T cells are now thought to constitute a
functional triad to promote obesity and obesity-associated
disorders [1–3,6–8]. Recently, the involvement of eosinophils
and B cells has also been demonstrated [24,25], implying that
many other immune cells participate in the physiologic and
pathologic processes of adipocyte hypertrophy. This may be a
natural process since adipose tissue is thought to be an ancestor of
lymphoid organs [5,14].
In the present study, we demonstrated that an innate
lymphocyte of the T cell lineage, the CD1d-restricted NKT cell,
also has an active role in the development of obesity. When fed an
HFD (CLEA Japan), CD1d
2/2 mice gained the least weight
compared to Ja18
2/2 and WT mice. This difference was
demonstrated when mainstream CD8
+ T cells were primarily
unaffected. Furthermore, similar results were obtained with
different types of HFD (Harlan Teklad [26] and our own original
preparation [18]), suggesting that the suppression of weight gain
was solely dependent on the deficiency of CD1d-restricted NKT
cells but not on the specific source of fat, i.e. fatty acid
composition.
Since Ja18
2/2 mice gained comparable BW as WT mice, the
residual CD1d-restricted, type II NKT cells appeared to
contribute to the accumulation of visceral fat in the body. In
HFD-fed WT and Ja18
2/2 mice, the number of NK1.1
+TCRb
+
cells increased along with the hypertrophic change of abdominal
WAT (Figure 4, 6), whereas the a-GalCer-CD1d dimer
+
population did not change in adipose tissue of WT mice,
suggesting that the type II NKT cells were the major population
affecting adipose tissue metabolism. Accordingly, the transfer of
NKT cells from Ja18
2/2 mice to CD1d
2/2 mice resulted in
weight gain and significant increase in insulin resistance (Figure
S4). Both the percentage and the cell number of NK1.1
+TCRb
+
cells in adipose tissue correlated with the BW weights in Ja18
2/2
Figure 6. Flow cytometric analyses of NKT cells in adipose tissue in mice fed an SFD or an HFD. (A) A representative flow cytometric dot-
plot defining the population of a-GalCer/CD1d dimer
+TCRb
+ and NK1.1
+TCRb
+ cells in adipose tissue of SFD-fed mice (a, c) and HFD-fed mice (b, d).
(B) The proportion of each subset in SVF. NK1.1
+TCRb
+ cells (a), CD4
+ (b), CD8
+ (c), and CD4
2CD8
2 (d) NKT cells (n=3–6 female mice in each group).
Representative data of three similar experiments are shown. The results are expressed as mean 6 s.d. Statistical analysis was performed according to
the Tukey-Kramer test. *p,0.05, **p,0.01. (C) The correlation between BW and the percentage of NKT cells in SVF by Pearson’s correlation coefficient
(R
2) test. WT (a), P=0.000006; Ja18
2/2 (b), P=0.004; and CD1d
2/2 (c), P=0.2. Values with P,0 .05 were considered statistically significant.
doi:10.1371/journal.pone.0030568.g006
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the F4/80
+CD11b
+ population in perigonadal adipose tissue in HFD-fed mice. F4/80
hi (Population 1; red gate) and F4/80
low,2 (Population 2; blue
gate) are set to a staining with isotype control mAb. (B) The percentage of cells of CD11b
+ (total) (a), Population 1 (b) and Population 2 (c). (C) CD1d
expression by the Population 1 and Population 2 (a), MFI in WT (b) and Ja18
2/2 (c) mice fed an HFD (n=3–4 male mice in each group). The results are
expressed as mean 6 s.d. Statistical analysis was performed according to the Tukey-Kramer test. *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0030568.g007
Figure 8. Cytokine production by MQ in perigonadal adipose tissue upon stimulation with LPS. (A–C) IL-10, GM-CSF and TNF-a
concentrations after stimulation of MQ in perigonadal adipose tissue with LPS (1 mg/ml) for 20 h (n=3–4 male mice in each group). Representative
data of three similar experiments are shown. The results are expressed as mean 6 s.d. Statistical analysis was performed according to the Tukey-
Kramer test. *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0030568.g008
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CD1d
2/2 mice (Figure 6C). When the NK1.1
+TCRb
+ cells in
adipose tissue were analyzed, we were unable to detect these cells
with sulfatide-loaded CD1d-multimers that are specific for a subset
of type II NKT cells [27] (data not shown). Of note, these cells
exhibited a biased repertoire in specific Vbs in HFD-fed WT mice
(data not shown), although the significance of this finding remains
unclear. It should also be noted that a-GalCer administration did
not boost weight gain in WT mice fed an HFD, although insulin
action was blunted with a-GalCer administration. This result
indicated that insulin resistance but not adiposity could be
reproduced through the activation of type I NKT cells (Figure
S1A).
Nishimura et al demonstrated that CD8
+ T cells are important
for recruitment of Mw and chronic inflammation in adipose tissue,
which was proposed to propagate inflammation [6]. In our
experiments, the CD8
+ subset of NK1.1
+ T cells, a rather rare
subset [28], increased in adipose tissue in WT and Ja18
2/2 mice.
Although we have not analyzed TCR Vb chain usage, Nishimura
described them as Vb7 and Vb10b [6]. Since Vb7 is one of the
preferred Vb chains of NKT cells [29], it is possible that these cells
or a portion of these cells include NKT cells. Very recently,
Mantell et al. reported that no protection against metabolic
abnormalities was noted in CD1d
2/2 mice fed an HFD [30].
They demonstrated no significant differences between WT and
CD1d
2/2 mice in physiologic, metabolic, and inflammatory
parameters. Nevertheless, since there was an early and reversible
decrease in liver NKT cells, mice appeared to respond to an HFD.
Specific reasons for these divergent findings will need to be
explored in future studies. One possibility might be the
colonization of mice from different animal facilities with different
flora. An important role of intestinal flora in the process of obesity
has emerged [31], and the differential dominance of certain
species of microbes has been demonstrated in obese or anorexic
human individuals [32]. Furthermore, in toll-like receptor 5
knockout (TLR5
2/2) mice, metabolic syndrome was induced by
altered gut microbiota with hyperphagic traits [33]. Moreover,
these metabolic changes could be conferred to WT, germ-free
mice upon transfer of the gut microbiota derived from TLR5
2/2
mice. Although adaptive immunity is not directly related to the
process of obesity in TLR5
2/2 mice, it should be noted that the
development of adiposity could be controlled by balancing the
complex microbiota. Since bacterial colonization in the intestine is
regulated by a CD1d-dependent, NKT cell-mediated mechanism
[34], it is possible that NKT cell deficiency may alter the intestinal
flora, and thus influence either an adipogenic or anti-adipogenic
host milieu.
The recruitment of Mw towards visceral fat, also known as
adipose tissue Mw (ATMw; CD11b
+F4/80
+), has also been
thought to be a hallmark of obesity [1,2]. The F4/80
+ fraction
can be subdivided into the F4/80
high and F4/80
low populations
[35]. In the present study, ATMw of WT and Ja18
2/2 mice had
an increased F4/80
high population, whereas CD1d
2/2 mice
predominantly had an increased percentage and number of the
Figure 9. Glucose and insulin tolerance. (A) (IPGTT). Glucose (1 g/kg BW) was administered i.p. to female mice fed an SFD or an HFD. (B) The
serum level of insulin 0 min and 120 min after glucose administration (i.p.) to HFD-fed mice was quantified by ELISA. (C) ITT. Insulin (0.75 U/kg BW)
was administered i.p. to HFD-fed mice (n=3–4 female mice in each group). Representative data of three similar experiments are shown. The results
are expressed as mean 6 s.d. Statistical analysis was performed according to the Tukey-Kramer test. *p,0.05 (WT versus CD1d
2/2);
#p,0.05 (Ja18
2/2
versus CD1d
2/2).
doi:10.1371/journal.pone.0030568.g009
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low population. The F4/80
high population exhibits higher
expression of TLR-4, TNF-a, and PPARc than the F4/80
low
population. Therefore, this subset represents pro-inflammatory
Mw (M1) and accumulates in adipose tissue of obese mice [36]. On
the other hand, the F4/80
low population exhibits higher IL-4
expression and represents anti-inflammatory Mw [36]. Further-
more, elimination of the F4/80
high population is associated with
improved insulin sensitivity [37]. Our studies suggest that the
predominance of F4/80
high ATMw is likely dependent on the
presence of type II NKT cells, since it was observed in WT and
Ja18
2/2 mice. Consistently, SVF that contained more F4/80
low
Mw from CD1d
2/2 mice produced more IL-10 upon stimulation
with LPS (Figure 8). The anti-inflammatory milieu induced by Mw
polarization may ameliorate the development of obesity in
CD1d
2/2 mice. It should also be noted that F4/80
high ATMw
expressed higher levels of CD1d than F4/80
low Mw in WT and
Ja18
2/2 mice, suggesting that NKT cells might better polarize
these cells to cause adipose tissue inflammation. Alternatively, F4/
80
high ATMw might express higher levels of CD1d as a result of
the interaction with type II NKT cells.
The present study suggests that type II NKT cells may serve as a
potential target for controlling the volume of visceral fat and
insulin resistance. A possible approach may be the administration
of a CD1d-binding ligand to modulate NKT cell function. Indeed,
Ilan’s group has demonstrated that the administration of
glucocerebroside (b-glucosylceramide; b-GlcCer) or the direct
transfer of NKT cells ameliorated metabolic aberration and
steatohepatitis of leptin-deficient ob/ob mice [38,39]. They
demonstrated that the therapeutic effects of b-GlcCer were
associated with a Th2-shift (decreased IFN-c and increased IL-
10) and the redistribution of NKT cells in the liver to the
periphery. Furthermore, b-GlcCer modulated the lipid rafts of
NKT cells, thus altering the expression of molecules of cellular
signaling, such as flotillin-2, Lck, and STAT1 [40]. Although the
mode of action appears to be dependent on iNKT cells, it remains
possible that these CD1d-binding non-stimulatory ligands may
simply function as antagonists for all CD1d-restricted NKT cells.
Of special interest, Lynch et al. demonstrated that NKT cells
and CD1d
+ cells are abundantly detected in the omentum tissue in
humans [41]. Half of the NKT (CD3
+CD56
+) cells stained with
the 6B11 mAb [42], indicating that they were iNKT cells, but the
remaining cells likely are type II NKT cells. They also reported a
net decrease of iNKT cells in severely obese individuals with a
relative increase of CD56
+ T cells (healthy, 49.9%; obese, 61.9%)
and discussed that the relative immunocompromised status in
obesity due to the decreases in iNKT cells might be related to
sensitivity to infections [40]. On the other hand, the omentum
may be a source of not only iNKT cells but also type II NKT cells
that are capable of inducing adiposity in the abdominal cavity.
In conclusion, we showed that deficiency of CD1d-resricted
NKT cells suppressed the development of obesity, likely because
inflammation of adipose tissue and liver were ameliorated and
reduced levels of insulin resistance were induced. NKT cells,
especially the type II subset, may be the initial subset of T cells that
recognizes and responds to lipid excess. Thus, CD1d-restricted,
type II NKT cells may be a novel target for therapeutic
intervention in the metabolic syndrome. Searching for regulatory
ligands and novel ways of regulation that include the selective
elimination of pathogenic type II NKT cells might permit the
control of not only metabolic syndrome but also various diseases
related to lipid inflammation mediated by NKT cells [43].
Supporting Information
Figure S1 BW and insulin resistance of mice adminis-
tered a-GalCer. (A) BW was determined weekly in WT mice
given either vehicle or a-GalCer (0.1 mg/g BW). (B) ITT was
performed for WT mice injected with vehicle or a-GalCer (n=5
female mice in each group). Representative data of two similar
experiments are shown. The results are expressed as mean 6 s.d.
Statistical analysis was performed according to the Student’s t-test.
*p,0.05.
(TIFF)
Figure S2 Serum T-chol-, HDL-chol, and TG levels. (A–
C) Serum T-chol-, HDL-chol, and TG level after an 18 wk
feeding and a 16 h fasting period (n=6–8 female mice in each
group). Representative data of three similar experiments are
shown. The results are expressed as mean 6 s.d. Statistical analysis
was performed according to the Tukey-Kramer test. *p,0.05,
**p,0.01.
(TIFF)
Figure S3 Dynamics of NKT cells in liver and adipose
tissue during the early phase of feeding. The cell number of
iNKT cells and NK1.1
+TCRb
+ cells in liver (A) and in adipose
tissue (B) at 1, 2, 3, and 18 wk of HFD-feeding (n=3–6 female
mice in each group). Representative data of two similar
experiments are shown. The results are expressed as mean 6 s.d.
(TIFF)
Figure S4 Effects of adoptive transfer of Ja18
2/2 HMNC
to CD1d
2/2 mice. (A) CD1d
2/2 mice received HMNC
(1610
6) from Ja18
2/2 mice since 8 wk of age on an HFD. BW
was determined weekly. (B, C) IPGTT and ITT were performed
at 14 wk of HFD feeding. (D) The number of NK1.1
+TCRb
+ cells
(a) and the CD4/8 proportion in liver and adipose tissue (b, c)
were analyzed by flow cytometry (n=5 male mice in each group).
Representative data of two similar experiments are shown. The
results are expressed as mean 6 s.d. Statistical analysis was
performed according to Student’s t-test. *p,0.05.
(TIFF)
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